The Impact of the Microbiome on Gynecological Cancers: Consequences for Diagnosis and Therapeutic Approaches - Scorecard - MDSpire

The Impact of the Microbiome on Gynecological Cancers: Consequences for Diagnosis and Therapeutic Approaches

  • By

  • Precious Adeoye Oyedokun

  • Bobola Timothy Oyeleke

  • Onigbinde Oluwanisola Akanji

  • Abraham Ololade Oyelaran

  • Kehinde Philip O

  • Grace Bosede Akanbi

  • Philip Olagbede Oyedokun

  • Marvelous Dasola Oyedokun

  • Chikezie Chinelo Naomi

  • Oyeniran Oluwatosin Imoleayo

  • Roland Eghoghosoa Akhigbe

  • April 23, 2026

  • 0 min

Share

Clinical Scorecard: The Impact of the Microbiome on Gynecological Cancers: Consequences for Diagnosis and Therapeutic Approaches

At a Glance

CategoryDetail
Condition
Key MechanismsMicrobial dysbiosis, chronic inflammation, immune modulation, loss of epithelial barrier integrity, estrogen metabolism, microbial metabolite toxicity.
Target Population
Care Setting

Key Highlights

  • Dysbiosis associated with HPV persistence and immune therapy resistance.

Guideline-Based Recommendations

Diagnosis

    Management

      Monitoring & Follow-up

      • Utilize microbial profiles to monitor treatment response and disease progression, with specific metrics.

      Risks

        Patient & Prescribing Data

        Probiotics, prebiotics, and dietary manipulation may improve outcomes; further evidence is needed.

        Clinical Best Practices

        • Educate patients about the microbiome's role in gynecological cancers.

        References

        Original Source(s)

        Related Content